Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max S Wicha

Showing results (141-150 of 209) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Investigation|January 7, 2010
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsChristophe Ginestier, Suling Liu, Mark E Diebel, et al.
Cell Death and Differentiation|October 14, 2017
IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancerDong Wang, Jiahui Xu, Bingjie Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 7, 2022
Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanomaMarisa E Aikins, You Qin, Hannah E Dobson, et al.
Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Scientific Reports|November 3, 2015
Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment optionsJoseph P Burnett, Hasan Korkaya, Maria D Ouzounova, et al.
Clinical & Experimental Metastasis|June 13, 2023
Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancerSophia M Orbach, Michael D Brooks, Yining Zhang, et al.
Clinical & Experimental Metastasis|August 24, 2022
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancerSophia M Orbach, Michael D Brooks, Yining Zhang, et al.
Cancer Letters|March 4, 2017
Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cellsJoseph P Burnett, Gi Lim, Yanyan Li, et al.
Pageof 21

Showing results (141-150 of 209) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Investigation|January 7, 2010
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsChristophe Ginestier, Suling Liu, Mark E Diebel, et al.
Cell Death and Differentiation|October 14, 2017
IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancerDong Wang, Jiahui Xu, Bingjie Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 7, 2022
Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanomaMarisa E Aikins, You Qin, Hannah E Dobson, et al.
Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Scientific Reports|November 3, 2015
Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment optionsJoseph P Burnett, Hasan Korkaya, Maria D Ouzounova, et al.
Clinical & Experimental Metastasis|June 13, 2023
Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancerSophia M Orbach, Michael D Brooks, Yining Zhang, et al.
Clinical & Experimental Metastasis|August 24, 2022
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancerSophia M Orbach, Michael D Brooks, Yining Zhang, et al.
Cancer Letters|March 4, 2017
Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cellsJoseph P Burnett, Gi Lim, Yanyan Li, et al.
Pageof 21